diacerein has been researched along with calcitriol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bauer, JW; Laimer, M; Prodinger, C; Reichelt, J | 1 |
1 review(s) available for diacerein and calcitriol
| Article | Year |
|---|---|
Epidermolysis bullosa: Advances in research and treatment.
Topics: Anthraquinones; Antibodies, Monoclonal, Humanized; Antimicrobial Cationic Peptides; Antineoplastic Agents, Immunological; Calcitriol; Carcinoma, Squamous Cell; Cathelicidins; Clinical Trials, Phase II as Topic; Epidermolysis Bullosa; Genetic Predisposition to Disease; Genetic Therapy; Humans; Immunotherapy; Immunotherapy, Active; Molecular Targeted Therapy; Multicenter Studies as Topic; Nivolumab; Palliative Care; Programmed Cell Death 1 Receptor; Prospective Studies; Research; Skin Neoplasms; Therapies, Investigational; Wound Healing | 2019 |
1 other study(ies) available for diacerein and calcitriol
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |